Blood pressure control in the setting of diabetes mellitus: New targets, new hope for improvement?

Journal of Human Hypertension

Volumn 20, Issue 9, 2006, Pages 635-637

  Varughese, G I ^a   Patel, J V ^a   Lip, G Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; DYSLIPIDEMIA; EPIDEMIC; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; HYPERTENSION; MICROANGIOPATHY; MORTALITY; NOTE; OBESITY; PRESCRIPTION; PREVALENCE; PRIMARY PREVENTION; STROKE; UNITED KINGDOM;

BLOOD PRESSURE; DIABETES MELLITUS; GREAT BRITAIN; HUMANS; HYPERTENSION;

EID: 33745077941     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002029     Document Type: Note

References (29)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42(6): 1206-1252.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365: 217-223.
3. Mayor S. Quarter of people with diabetes in England are undiagnosed. BMJ 2005; 331(7518): 656.
4. Wood JR, O'Riordan MA, Vogt BA, Pabmert MR. Blood pressure measurement in diabetes clinic: Are we paving enough attention? Diabetes Care 2006: 29(3): 743-744.
5. Hippisley-Cox J, Pringle M. Prevalence, care and outcomes for patients with diet-controlled diabetes in general practice: Cross-sectional survey. Lancet 2004; 363: 423-428.
6. Contreras F, Rivera M, Vasquez J, De la Parte MA, Velasco M. Diabetes and hypertension physiopathology and therapeutics. J Hum Hypertens 2000; 14: S26-S31.
7. Jonas M, Reicher-Reiss H, Boyko V, Behar S, Grossman E. Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension. J Hum Hypertens 2003; 17: 665-670.
8. Czupryniak L, Saryusz-Wolska M, Pawlowski M, Loba J. Elevated systolic blood pressure is present in almost all individuals with newly diagnosed diabetes. J Hum Hypertens 2006; 20: 231-233.
9. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diab Care 2004; 27(5): 1047-1053.
10. Campbell SM, Roland MO, Middleton E, Reeves D. Improvements in quality of clinical care in English general practice 1998-2003: Longitudinal observational study. BMJ 2005; 331: 1121-1123.
11. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. British hypertension society. Guidelines for management of hypertension: report of the fourth working party of the british hypertension society, 2004-BHS IV. J Hum Hypertens 2004; 18(3): 139-185.
12. Mayor S. NICE calls for wider use of statins. BMJ 2006; 332: 256.
13. Varughese GI, Patel JV, Lip GY, Varma C. Novel concepts of statin therapy for cardiovascular risk reduction in hypertension. Curr Pharm Des 2006; (11): (in Press).
14. Varughese GI, Lip GY. Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis. J Hum Hypertens 2005; 19(11): 851-853.
15. Karalliedde J, Viberti G. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes. J Hum Hypertens 2006 20(4): 239-253.
16. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
17. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al. HOT Study Group. Effects of intensive blood pressure-lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomized trial. Lancet 1998; 351: 1755-1762.
18. He FJ. MacGregor GA. Cost of poor pressure control in the UK: 62000 unnecessary deaths per year. J Human Hypertens 2003; 17: 455-457.
19. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 2002; 45: S13-S17.
20. Gulliford MC, Charlton J, Latinovic R. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: Clinical effectiveness or clinical discretion? J Hum Hypertens 2005; 19(2): 111-117.
21. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urine albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with the risk of death. Diabetes 2002; 51: 1157-1165.
22. Varughese GI, Lip GY. Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation. J Hum Hypertens 2005; 19(6): 421-424.
23. MacFadyen RJ, Lim HS. Emergence of structural arterial stiffness in diabetes and the role of abnormalities of autonomic tone in the sequence of events. J Hum Hypertens 2004; 18(11): 755-756.
24. Boero R, Prodi E, Elia F, Porta L, Martelli S, Ferraro L et al. How well are hypertension and albuminuria treated in type II diabetic patients? J Hum Hypertens 2003; 17: 413-418.
25. Steinbrook R. Facing the diabetic epidemic - mandatory reporting of glycosylated hemoglobin values in New York city. N Engl J Med 2006; 354: 545-548.
26. Kenny C. Diabetes and the quality and outcomes framework. BMJ 2005; 331: 1097-1098.
27. Roland M. Linking physicians pay to quality of care - a major experiment in the UK. N Engl J Med 2004; 351: 1448-1454.
28. Sutton M, McLean G. Determinants of primary medical care quality measured under the new UK contract: Cross sectional study. BMJ 2006; 332: 389-390.
29. Keen H. Diabetes and the quality and outcomes framework: Diabetes needs reintegration of primary and secondary care. BMJ 2005; 331(7528): 1340.